AI assistant
PAINCHEK LTD — Capital/Financing Update 2020
Mar 23, 2020
65534_rns_2020-03-23_763a3954-46bd-45b5-bfe2-f025ef48de8c.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [168 x 38] intentionally omitted <==
PainChek Limited ( ASX: PCK ) ABN 21 146 035 127 24 March 2020 Suite 401, 35 Lime Street, Sydney, NSW, 2000 Phone +61 8 9388 8290 [email protected]
PainChek receives federal government initiative payment of $1.25M
24th March 2020: T he Company refers to the ASX release dated 19 March 2020 wherein PainChek Ltd (ASX:PCK) advised that the 25,000 licensed bed milestone under the $5M grant agreement with the Federal Government had been achieved.
PCK has received the $1.25M from the Australian Federal Government which will be recognized as revenue in March 2020. This payment is in addition to the initial $500k payment that the Company received from the Federal Government in December 2019.
PainChek CEO Philip Daffas says that the Federal Government initiative is designed to provide all residents living with dementia with universal access to PainChek ® so they can receive the best care for them and their families.
This ASX announcement has been approved for release by Philip Daffas, Managing Director.
ENDS
For more information:
| Ian Hobson | Philip Daffas |
|---|---|
| Company Secretary, PainChek | CEO, PainChek |
| [email protected] | [email protected] |
| 0407 421 185 | 0406 537 235 |
==> picture [189 x 43] intentionally omitted <==
About PainChek®
PainChek® Ltd is an Australian based company that develops pain assessment technologies.
PainChek® is a smart-phone based medical device using artificial intelligence to assess and score pain levels in real time and update medical records in the cloud. PainChek® records a short video of the person’s face and analyses the images that indicate pain and records them.
Next, the caregiver uses PainChek® to record their observations of other pain related behaviours that complete the assessment. Finally, PainChek® calculates an overall pain score and stores the result allowing the caregiver to monitor the effect of medication and treatment over time.
PainChek® is being rolled out globally in two phases: first, PainChek® for adults who are unable to effectively verbalise their pain such as people with dementia, and second, PainChek® for Children who have not yet learnt to speak.
The PainChek® Shared Care Program is a PainChek® licensing model which enables a professional carer to share their resident or patient data securely with other healthcare professionals or designated homebased family carers for ongoing pain assessments or clinical data review.
To find out more, visit www.painchek.com
==> picture [215 x 217] intentionally omitted <==
PainChek[®] artificial intelligence assesses facial micro-expressions that are indicative of the presence of pain.
==> picture [215 x 216] intentionally omitted <==
PainChek[®] domains of pain assessment that calculates pain severity score.
==> picture [612 x 82] intentionally omitted <==